Coherus Oncology, Inc. Common Stock
CHRS
CHRS
187 hedge funds and large institutions have $1.22B invested in Coherus Oncology, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 54 increasing their positions, 78 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
187
Holders Change
-1
Holders Change %
-0.53%
% of All Funds
3.28%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
21
Increased
54
Reduced
78
Closed
21
Calls
$1.83M
Puts
$2.32M
Net Calls
-$488K
Net Calls Change
-$260K
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$115M |
| 2 |
SCM
2
Suvretta Capital Management
New York
|
$7.86M |
| 3 |
FAM
3
Fred Alger Management
New York
|
$6.95M |
| 4 |
PFC
4
Phocas Financial Corp
Alameda,
California
|
$8.11M |
| 5 |
5
Millennium Management
New York
|
$7.78M |
